Rivaroxaban NDC 72205-416

NDC codes

FDA NDC Directory

Product NDC (as listed)72205-416Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72205-0416Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
72205-416-02	72205041602	10 BLISTER PACK in 1 CARTON (72205-416-02) / 10 TABLET, FILM COATED in 1 BLISTER PACKMarketed from Mar 18, 2026
72205-416-03	72205041603	30 TABLET, FILM COATED in 1 BOTTLE (72205-416-03)Marketed from Mar 18, 2026
72205-416-04	72205041604	60 TABLET, FILM COATED in 1 BOTTLE (72205-416-04)Marketed from Mar 18, 2026
72205-416-05	72205041605	180 TABLET, FILM COATED in 1 BOTTLE (72205-416-05)Marketed from Mar 18, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Rivaroxaban
Generic name (nonproprietary): rivaroxaban
Active ingredients: Rivaroxaban — 2.5 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Novadoz Pharmaceuticals LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 208546
Marketing start: Oct 24, 2025
Listing expires: Dec 31, 2027
Other FDA classes: Factor Xa Inhibitors (Mechanism)
Identifiers: Product ID 72205-416_257ac149-46bc-48f3-b992-fe5bedbb9440SPL ID 257ac149-46bc-48f3-b992-fe5bedbb9440SPL set ID e8e4275c-6cbe-4976-8cae-f62baf954d27RxCUI 2059015UNII 9NDF7JZ4M3UPC 0372205416024, 0372205416031, 0372205416055, 0372205416048
Pharmacologic class: Factor Xa Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472205041602 followed by a unit qualifier and the quantity

Package 72205-0416-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 12, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Rivaroxaban tablets are a factor Xa inhibitor indicated: to reduce the risk of major cardiovascular events in patients with coronary artery disease (CAD) ( 1.7 ) to reduce the risk of major thrombotic vascular events in patients with peripheral artery disease (PAD), including patients after recent lower extremity revascularization due to symptomatic PAD ( 1.8 ) 1.7 Reduction of Risk of Major Cardiovascular Events in Patients with Coronary Artery Disease (CAD) Rivaroxaban tablets, in combination with aspirin, is indicated to reduce the risk of major cardiovascular events (cardiovascular death, myocardial infarction, and stroke) in adult patients with coronary artery disease. 1.8 Reduction of …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)